Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Alan Hartman

Alan Hartman has over 25 years of investment banking experience, having advised on many of the transactions that have helped transformed the healthcare sector over that time. Over the course of his career, Mr. Hartman has advised on almost $1 trillion of transactions, and has established himself as a leading advisor in the healthcare industry. He has advised in some of the largest and most complex transactions across every aspect of the industry, including:

  • Large Pharma - Advised Pfizer in multiple transactions including its $68bn acquisition of Wyeth; its $14bn acquisition of Medivation; its $5bn acquisition of Anacor; its $12bn sale of its nutritional business to Nestlé and its $18bn OTC JV with Glaxo; Astra Zeneca in its $40b acquisition of Alexion and its $15bn acquisition of MedImmune; Merck in its $3bn acquisition of Antelliq and its spinoff of its Organon division
  • Biotech - Advised Immunomedics in its $21bn sale to Gilead Sciences; Pharmacyclics in its $21bn sale to Abbvie; Immunex in its $16bn sale to Amgen and Onyx in its $10bn sale to Amgen; GW Pharmaceuticals in its $7b sale to Jazz Pharmaceuticals; Biogen in its defense against Icahn and acquisition of control of Tysabri for $3bn; InterMune in its $9bn sale to Roche; Receptos in its $8bn sale to Celgene; AveXis in its $8bn sale to Novartis; Spark in its $5bn sale to Roche; Tesaro in its $5bn sale to Glaxo; Forty Seven in its $4.5bn sale to Gilead; Principia in its $3.7bn sale to Sanofi and Translate Bio in its $3.2b sale to Sanofi
  • Specialty Pharma - Mylan in its $25bn merger with Pfizer’s Upjohn division and in $30bn of other acquisitions; Salix’s $16bn sale to Valeant and Questcor in its $6bn sale to Mallinckrodt
  • Healthcare Services - The buyout group led by KKR and Bain in the $33bn acquisition of HCA; Omnicare in its $13bn sale to CVS; Alliance Boots in its two step sale to Walgreens for $25bn; Bergen Brunswig in its $4bn merger with Amerisource
  • Healthcare REITs - Advised Ventas on over $20bn of deals over a 15 year period, including the acquisition of NHP for $7bn and the spin-off of Care Capital for $4bn
  • Medical Devices - Represented Boston Scientific in its $25bn hostile acquisition of Guidant
Mr. Hartman joined Centerview in 2009 after 16 years at Merrill Lynch, where he was head of Americas Mergers & Acquisitions. He received a BS in Economics from the Wharton School of the University of Pennsylvania and a JD from Harvard Law School. He spent four years as a corporate attorney at Skadden Arps prior to joining Merrill Lynch. He is on the boards of Weill Cornell Medicine, FARE (Food Allergy Research & Education) and The Kelly Writers House at the University of Pennsylvania, as well as being on the finance committee and co-head of the annual fund of Nantucket Cottage Hospital. Together with his wife and three children, he founded the Fund For New Leadership, a new philanthropic venture that provides early support to emerging social change leaders from cities and towns across the country.

Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
Red Collar Pet Foods, Inc.
Announced: Q1 2023
Status: Pending

Exclusive financial advisor to Red Collar on its sale of a treats factory to Nestlé Purina PetCare
View All
New York

Centerview Partners LLC

31 West 52nd Street

22nd Floor

New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax

Centerview Partners UK LLP

100 Pall Mall

3rd Floor

London SW1Y 5NQ

02074099700 | Tel
02074099704 | Fax

Centerview Partners France SCS

16 Avenue Matignon

4th Floor

Paris 75008

0180200620 | Tel
0180200621 | Fax
Palo Alto

Centerview Partners LLC

600 Ramona St.

Suite 300

Palo Alto, California 94301

(650) 822-5800 | Tel
(650) 822-5801 | Fax
San Francisco

Centerview Partners LLC

555 California Street

Suite 4300

San Francisco, California 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax

Copyright © 2008 - 2023 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC